Microparticles and colorectal cancer
Pathology - Research and Practice · 2026
DOI: 10.1016/j.prp.2026.156660 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Hamid Reza Nejabati und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry and Clinical Laboratories, Faculty of Medi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell-Derived Microparticles. Die Arbeit nennt 88 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Colorectal cancer (CRC) ranks as the third most prevalent cancer worldwide, with nearly 2 million new cases diagnosed annually. Patients with solid tumors are widely recognized to often exhibit abnormal activation of the coagulation system, leading to a high prevalence of thromboembolism (VTE). Microparticles (MPs) are a subset of extracellular vehicles (EVs) that differ from exosomes and apoptotic bodies primarily in their size, composition, and mechanisms of formation and release. MPs are integral to tightly controlled biological processes, including hemostasis, inflammation, and protein transfer. The impact of platelet-tumor interactions varies with the environment-either local tissue or circulation-leading to either inhibition or promotion of cancer progression. Also, Tumor-derived microvesicles (TMVs) play an essential role in tumor progression by affecting the biological functions of immune cells such as lymphocytes, monocytes, and macrophages. This interaction is particularly significant in CRC, where macrophages contribute to tissue recovery processes. It is proposed that cancer patients experiencing VTE exhibited significantly greater mean TF (+) MPs activity compared to those without VTE. PS-positive platelets and MPs have a role in the hypercoagulable state of CRC patients and may serve as promising therapeutic targets to prevent coagulation in this population. Circulating MPs, especially fibrin-bearing MPs, may serve as novel biomarkers for predicting thrombo-embolic complications and poorer prognosis in cancer patients. In this review article, we have explored various MPs in CRC, especially those are related to hypercoagulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic…
- Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Histology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: roshangarl@tbzmed.ac…
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Nejabati, H. R., Fattahpour, S. F., & Roshangar, L. (2026). Microparticles and colorectal cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156660
Vancouver
Nejabati HR, Fattahpour SF, Roshangar L. Microparticles and colorectal cancer. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2026.156660
BibTeX
@article{Nejabati2026,
author = {Nejabati, Hamid Reza and Fattahpour, Seyedeh Farinaz and Roshangar, Leila},
title = {Microparticles and colorectal cancer},
journal = {Pathology - Research and Practice},
year = {2026},
doi = {10.1016/j.prp.2026.156660}
}
EUVIMED